Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia

Clinical trial NCT00889707 · COMPLETED

Trial details

NCT number: NCT00889707
Sponsor: Sophiris Bio Corp
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2009-01-01
Primary completion: 2009-12-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.